|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
|
|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||
| Net loss | ||||
| Adjustments to reconcile loss to net cash used in operating activities: | ||||
| Cost of share-based payments | ||||
| Changes in operating assets and liabilities: | ||||
| Increase in other current assets | ||||
| Increase/(decrease) in accounts payable | ||||
| (Decrease)/increase in accrued liabilities | ||||
| Increase in employee compensation and benefits | ||||
| Net cash used in operating activities | ||||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||
| Net cash provided by (used in) investing activities | ||||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||
| Issuance costs related to initial public offering | ||||
| Initial Public Offering | ||||
| Total issuance costs related to initial public offering | ||||
| Proceeds from exercise of warrants, options, and preferred investment options | ||||
| Issuance costs related to the exercise of warrants, and preferred investment options | ||||
| Issuance costs related to private placement | ||||
| Private Placement | ||||
| Total issuance costs related to private placement | ||||
| Net cash provided by financing activities | ||||
| INCREASE/(DECREASE) IN CASH AND CASH EQUIVALENTS | ||||
| CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD | ||||
| CASH AND CASH EQUIVALENTS AT END OF PERIOD | ||||
Loading...